Stock Analiz

SBC Medical Group Holdings Inc SBC

Medical/Nursing Services · IPO 2022 · data as of November 13, 2026

$7.35Market cap $756M
Open the interactive analysis →

SBC Medical Group Holdings Inc (SBC) is a healthcare company listed in the US with a market value of about $756M. In the twelve months to September 30, 2026 it had revenue of $190M and net income of $52M, a net margin of 27.3%.

Its overall Stock Analiz score is 2.6 out of 5 (average). The strongest part is financial health (5/5); the weakest is future growth (1/5).

Key numbers: a P/E of 14.7, a price to free cash flow of 7.5, a 5-year average ROIC of 20%. A discounted cash flow model with moderate assumptions puts its intrinsic value about 44% above the current price.

About SBC Medical Group

SBC Medical Group is listed in the US and classified in medical/nursing services, IPO year 2022. It was profitable in 3 of the last 3 years in our data.

Score: 2.6 / 5

Value4/5
Future growth1/5
Track record2/5
Financial health5/5
Shareholder returns1/5

Checks passed

  • P/E below 25
  • P/E below the industry median
  • P/FCF below 20
  • Price below intrinsic value (DCF, moderate assumptions)
  • Profit margin improving
  • 5-year average ROIC above 12%
  • ROE above 15%
  • More cash than debt, or low debt to equity

Checks not passed

  • PEG below 1.5
  • Revenue growth above 10% last year
  • 3-year revenue growth above 10% a year
  • 3-year free cash flow growth above 10% a year
  • Strong R&D investment or growth above 20%
  • 5-year EPS growth above 10% a year
  • 5-year revenue growth above 8% a year
  • Profitable 5 years in a row

Valuation

P/E (TTM)14.7
Forward P/E14.3
P/FCF7.5
P/S4.0
P/B2.6
EV/EBITDA7.6
PEG—
Dividend yield0.00%
FCF yield13.3%
Shareholder yield0.7%
Intrinsic value vs. price+44%

Growth and quality

Revenue growth (1 yr)-15.5%
Revenue growth (5 yrs, per year)—
EPS growth (5 yrs, per year)—
FCF growth (3 yrs, per year)—
Net margin (5-yr avg.)24.1%
ROIC (5-yr avg.)19.5%
Profitable years (of last 10)3
Years paying a dividend—

Financials, last 3 years

Fiscal yearTTM202520242023
Revenue$190M$174M$205M$194M
Net income$52M$51M$47M$39M
Free cash flow$100M$23M$18M$42M
EPS (diluted)$0.50$0.50$0.48$0.42
Net margin27.3%29.4%22.7%20.3%
ROIC—14.0%21.6%23.0%

From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.

What analysts expect

The average 12-month price target from 4 analysts is $9.25, 26% above the current price; targets range from $7.00 to $11.00; the consensus rating is “Strong buy”; expected EPS is $0.46 for the fiscal year ending December 31, 2026.

Frequently asked questions

What is SBC Medical Group’s P/E ratio?

About 14.7, based on the last twelve months of diluted earnings per share (forward P/E about 14.3).

Is SBC Medical Group stock undervalued?

Our DCF model with moderate assumptions puts its intrinsic value about 44% above the current market value. A model is a range, not a promise; try your own assumptions in the DCF calculator.

Does SBC Medical Group pay a dividend?

Not currently.

Is SBC Medical Group a good stock to buy?

We do not give buy or sell advice. SBC Medical Group scores 2.6 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.

Similar companies

Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.